This content was written and submitted by the supplier. It has only been modified to comply with this publications space and style.
Aptar Digital Health, a developer of Software as a Medical Device (SaMD), digital Patient Support Programs (PSPs), and disease management solutions, has announced a new partnership with Legit.Health, an artificial intelligence-based, medical device software company that focuses on the early detection, evaluation, and monitoring of skin diseases.
Legit.Healths technology, which supports the diagnosis of approximately 300 conditions including atopic dermatitis, psoriasis, and skin cancer, will be integrated into Aptar's Digital Health proprietary platform. Focused on enhancing patient care and increasing patient autonomy, this advanced digital solution will support healthcare professionals (HCPs) to diagnose skin conditions earlier and will enable patients to start treatment plans sooner to improve their overall quality of life. The solution also may be used to facilitate patient enrollment in clinical trials.
Legit.Health's use of AI for monitoring disease progression through automated, clinically validated scoring systems, such as the Psoriasis Area Severity Index (PASI) and SCORing Atopic Dermatitis (SCORAD), will be leveraged within this partnership. This will help to ensure patients receive the most accurate and timely information to manage and treat their skin condition more effectively. The AI-powered technology also extends to the quantification of the intensity, count, and extent of the visible clinical signs of skin conditions, offering HCPs a more precise measure of disease severity, an indicator considered critical in determining the most appropriate treatment.
This strategic partnership is set to drive digital transformation in the healthcare sector. Aptar Digital Health andLegit.Healthtogether will pave the way towards harnessing the power of AI to improve patient experiences and outcomes in immuno-dermatology.
Sai Shankar, President, Aptar Digital Health, stated, Since 2021, Aptar Digital Health has been growing our portfolio of technology partners to provide improved solutions for patients in multiple therapeutic areas such as cardiology, neurology and visual acuity. With this new partnership, Aptar Digital Health is acquiring the ability to leverage AI technology to accelerate the diagnosis and monitoring of skin conditions.
Andy Aguilar, CEO and Co-Founder ofLegit.Health, commented, One of our main aims within the medical assistance process in the field of dermatology is to be able to offer patients the opportunity of having the earliest and most accurate diagnosis, with the appropriate referral and treatment to reduce uncertainty and waiting times. She added, Legit.Health's technology helps the medical practitioner to provide this kind of care to their patients and today, thanks to our partnership with Aptar Digital Health, we will be able to reach even more people who will benefit from our service
See original here:
- Recognizing Topical Steroid Withdrawal and Advancing Therapeutic Precision - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Examining the Halfway Mark of 2025 in Dermatology - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Summertime skin protection strategies | Dermatology Associates of Ithaca - 607 News Now - June 10th, 2025 [June 10th, 2025]
- Retinol Market Set to Witness Surge in Dermatology and Skincare Applications | RoC, The Ordinary - openPR.com - June 10th, 2025 [June 10th, 2025]
- Chronic Itch Pathophysiology and Therapeutic Advances - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Adam Friedman, MD, FAAD: Spotlighting Disparities in Lichen Planus Screening and Treatment - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Addressing Overlapping Pathophysiology and Patient Burden in Atopic Dermatitis and Alopecia Areata - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Road to RAD: Whats Next in the AD Pipeline? - Dermatology Times - June 10th, 2025 [June 10th, 2025]
- Revolutionizing Onco-Dermatology Techniques and Managing Adverse Effects - CancerNetwork - June 1st, 2025 [June 1st, 2025]
- Practical Strategies for Harnessing AI and Social Media in Dermatology - Dermatology Times - June 1st, 2025 [June 1st, 2025]
- The Medical Sisterhood: Expertise into InfluenceOwning the Podium in Dermatology, with Amy Spizuoco, DO - HCPLive - June 1st, 2025 [June 1st, 2025]
- Recognizing Melanoma and Skin Cancer Awareness Month 2025 - Dermatology Times - June 1st, 2025 [June 1st, 2025]
- Clinical and Conference Insights from a Dermatology PA Leader - Dermatology Times - June 1st, 2025 [June 1st, 2025]
- Beyond the Clinic: How the Mobile Destination Healthy Skin Initiative Saved Peter Graylins Life - Dermatology Times - June 1st, 2025 [June 1st, 2025]
- Integrating Ruxolitinib, Excimer Laser, and Emerging Therapies for Vitiligo - Dermatology Times - June 1st, 2025 [June 1st, 2025]
- Some Major Key Players In The AI-Powered Drug Discovery in Dermatology Market: - InsightAce Analytic - June 1st, 2025 [June 1st, 2025]
- Revolutionizing Acne Treatments and Skin Care with Cold Plasma Technology - Dermatology Times - May 21st, 2025 [May 21st, 2025]
- Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor - Dermatology Times - May 21st, 2025 [May 21st, 2025]
- Weighing In on Biologics and JAK Inhibitors for Atopic Dermatitis - Dermatology Times - May 21st, 2025 [May 21st, 2025]
- Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for AD - Dermatology Times - May 21st, 2025 [May 21st, 2025]
- Health-E Commerce launches Collaboration with Healthcare Marketplace Sesame to Expand Access to Mental Health and Dermatology Care on FSA Store and... - May 21st, 2025 [May 21st, 2025]
- Dermatology of the Rockies Among First in Colorado to Offer Latest Noninvasive Brain Stimulation Technology to Optimize Mental Health - Morningstar - May 21st, 2025 [May 21st, 2025]
- Latest Acne and Rosacea Therapies Unveiled at Dermatology Week - HMP Global Learning Network - May 21st, 2025 [May 21st, 2025]
- Lilly Dermatology and UPHS talk Skin Cancer Awareness - WZMQ 19 News - May 12th, 2025 [May 12th, 2025]
- Vet Watch: Tips and pitfalls of dermatology in the new age of isoxazolines - DVM360 - May 12th, 2025 [May 12th, 2025]
- Missed Diagnoses, Missed Opportunities: Closing the Gap in Skin Cancer for Patients of Color - Dermatology Times - May 12th, 2025 [May 12th, 2025]
- The State of Melanoma Care: Advances, Access, and the Road Ahead - Dermatology Times - May 12th, 2025 [May 12th, 2025]
- Protagonist Announces Icotrokinra Phase 3 Data on Difficult-to-Treat Scalp and Genital Psoriasis and Preclinical Data on PN-881 Presented at the... - May 12th, 2025 [May 12th, 2025]
- Business Bites: Job Service, Epiphany Dermatology moving; student art exhibition; local yarn shop day; fundraising to save historic barn; block party;... - April 27th, 2025 [April 27th, 2025]
- Dermatology Excimer Laser Market Size to Hit USD 1,725.35 Million by 2034 - Precedence Research - April 27th, 2025 [April 27th, 2025]
- Skin of Color Dermatology Substantially Improved in Last 20 Years - Drug Topics - April 19th, 2025 [April 19th, 2025]
- How Anastasia Georgievskaya and SkinGPT Are Addressing Gaps in the Dermatology Industry - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- Shawn Kwatra, MD, Endowed as Dr. Joseph Warren Burnett Professor of Dermatology at the University of Maryland School of Medicine - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- Utility of Head-to-Head Studies in Atopic Dermatitis and Future Research Directions - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- Treating Rosacea and Other Concerns with Generative Skins Ingredient Library - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- Case 1: Experts on a GPP Emergency Case and Effisayil 1 Trial Results - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- Utility of Head-to-Head Studies in Psoriasis Management - Dermatology Times - April 19th, 2025 [April 19th, 2025]
- AAD Reading Room | DEI in Dermatology: Past, Present -- and Future - MedPage Today - April 10th, 2025 [April 10th, 2025]
- Epidemiological Study on Palmoplantar Pustulosis in Korea Highlights Disease Burden and Treatment Gaps - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- Championing Patient and Consumer Safety in Dermatology - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- Addressing Diagnostic Ambiguity and Expanding Therapeutic Options in CHE - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- The Future of laBCC Treatment with Vishal Patel, MD, FAAD, FACMS - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- Shaping the Future of Dermatology With Insights From AAD 2025 and Beyond - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- Overcoming Therapeutic Inertia in a 25-Year-Old Man with Moderate to Severe Atopic Dermatitis - Dermatology Times - April 10th, 2025 [April 10th, 2025]
- Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 3 - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Top 5 Articles of the Month: March - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Talking to Patients on Sunscreen Application and the Effects of Visible Light - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Clinical Experience and Diagnosis of GPP - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Gene Expression Profiling and Other Molecular Tests Utilized for Melanoma and Squamous Cell Carcinoma - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Fixed-Dose Acne Treatment Gel is Safe and Effective for Hispanic Patients, According to Post-Hoc Analysis - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- CBD and CBG Ointment Improved Skin in Patients with Atopic Dermatitis - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma - Dermatology Times - March 30th, 2025 [March 30th, 2025]
- Hims & Hers shutters Apostrophe in favor of its own tele-dermatology offerings - Fierce healthcare - March 15th, 2025 [March 15th, 2025]
- Closing Out AAD With Dermatology Times Editor in Chief - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Improving Patient Care in Dermatology Through Data, Innovation, Advocacy: AAD 2025 Recap - AJMC.com Managed Markets Network - March 15th, 2025 [March 15th, 2025]
- Inflammatory Arthropathy Risk Increased in Patients With Hidradenitis Suppurativa - Dermatology Advisor - March 15th, 2025 [March 15th, 2025]
- Expert Perspectives: Dermatology's Top Story to Watch in 2025 - MD Magazine - March 15th, 2025 [March 15th, 2025]
- Whats New in Dermatology for Pigmentary Disorders, with Andrew Alexis, MD, MPH - MD Magazine - March 15th, 2025 [March 15th, 2025]
- Home Phototherapy Proves Effective and Preferred in LITE Study for Psoriasis Treatment - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Efficacy, Safety, and Role in Therapy of JAK Inhibitors for Atopic Dermatitis - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Reviving the Classics: The Role of Older Medications in Modern Dermatology - AJMC.com Managed Markets Network - March 15th, 2025 [March 15th, 2025]
- Dermatology Therapeutics: Updates for Primary Care from AAD 2025 - Patient Care Online - March 15th, 2025 [March 15th, 2025]
- Advances in Dermatology Therapeutics: Key Insights from AAD 2025 - Patient Care Online - March 15th, 2025 [March 15th, 2025]
- The Impact of JAK Selectivity in Atopic Dermatitis Treatment - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Social Drivers of Health Success Stories in Dermatology | AAD 2025 - Managed Healthcare Executive - March 15th, 2025 [March 15th, 2025]
- Improving Acne Treatment Through Antibiotic Stewardship and Gut-Skin Health - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Advancing Recognition and Treatment of Allergic Contact Dermatitis - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- Lebrikizumab Shows 3-Year Sustained Efficacy in AD - Dermatology Times - March 15th, 2025 [March 15th, 2025]
- AAD 2025: Galderma to Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leadership and Strong Momentum -... - March 5th, 2025 [March 5th, 2025]
- What to Look Forward to at the American Academy of Dermatology Annual Meeting 2025 - MD Magazine - March 5th, 2025 [March 5th, 2025]
- Recognizing the Achievements of Women in Dermatology - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- The Solar Spectrum and Impact on Skin Health - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- The Undetectable Era: How Patients Are Shifting Towards More Natural-Looking Results at the Clinic - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- Researchers overseas: Radiology has become indispensable to dermatology - Radiology Business - March 5th, 2025 [March 5th, 2025]
- Defining Alopecia Areata Severity and Navigating Treatment Options - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- Acne and TikTok: What Do Dermatologists Need to Know? - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- Celebrating Womens History Month with Mindy Haws, MD, and the LIMITLESS Initiative - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- A Case-Based Approach to Topical and Nonsteroidal AD Management - Dermatology Times - March 5th, 2025 [March 5th, 2025]
- Dermatology Partners Opens State-of-the-Art Dermatopathology Laboratory - citybiz - February 25th, 2025 [February 25th, 2025]